Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) - JSON Representation

Raw json | Download

{
  "resourceType" : "ArtifactAssessment",
  "id" : "179693",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2025-09-13T09:36:24.241Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/certainty-of-evidence"🔗 ,
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-assessment"
    ]
  },
  "text" : {
    "status" : "additional",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty evidence (GRADE)</p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown" : "This example of a CertaintyOfEvidence Profile shows a recursive pattern of component elements with type/classifier paired values for different aspects of rating the certainty of evidence."
    },
    {
      "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code" : "active",
            "display" : "Active"
          }
        ]
      }
    }
  ],
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net/FOI",
      "value" : "179693",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "title" : "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)",
  "citeAs" : "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179693. Revised 2025-09-13. Available at: https://fevir.net/resources/ArtifactAssessment/179693. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179693#json.",
  "artifactReference" : {
    🔗 "reference" : "Evidence/55",
    "type" : "Evidence",
    "display" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"
  },
  "content" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "https://fevir.net/resources/CodeSystem/179423",
            "code" : "rating-system",
            "display" : "Rating System"
          }
        ]
      },
      "classifier" : [
        {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/uv/ebm/CodeSystem/evidence-rating-system-classifier-codesystem",
              "code" : "GRADE",
              "display" : "GRADE"
            }
          ]
        }
      ],
      "freeToShare" : true
    },
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://hl7.org/fhir/certainty-type",
            "code" : "Overall",
            "display" : "Overall certainty"
          }
        ]
      },
      "classifier" : [
        {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/certainty-rating",
              "code" : "low",
              "display" : "Low quality"
            }
          ]
        }
      ],
      "freeToShare" : true
    }
  ]
}